Hana A. Mansour

ORCID: 0000-0003-0634-3429
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal and Macular Surgery
  • Intraocular Surgery and Lenses
  • Glaucoma and retinal disorders
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Artificial Intelligence in Healthcare and Education
  • Ocular Diseases and Behçet’s Syndrome
  • Ocular and Laser Science Research
  • Vascular Malformations Diagnosis and Treatment
  • Ocular Infections and Treatments
  • Retinal Development and Disorders
  • Traumatic Ocular and Foreign Body Injuries
  • Cardiac, Anesthesia and Surgical Outcomes
  • Drug-Induced Ocular Toxicity
  • Ophthalmology and Visual Health Research
  • Surgical Simulation and Training
  • Injury Epidemiology and Prevention
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Ophthalmology and Visual Impairment Studies
  • Parasitic Diseases Research and Treatment
  • Disaster Response and Management
  • Ophthalmology and Eye Disorders
  • Inflammasome and immune disorders
  • Corneal surgery and disorders

American University of Beirut
2014-2024

Wills Eye Hospital
2023-2024

Thomas Jefferson University
2023-2024

American University of Beirut Medical Center
2021-2024

Thomas Jefferson University Hospital
2024

University of Arkansas for Medical Sciences
2022

Rafik Hariri University Hospital
2019

Purpose of review This seeks to provide a summary the most recent research findings regarding utilization ChatGPT, an artificial intelligence (AI)-powered chatbot, in field ophthalmology addition exploring limitations and ethical considerations associated with its application. Recent ChatGPT has gained widespread recognition demonstrated potential enhancing patient physician education, boosting productivity, streamlining administrative tasks. In various studies examining utility...

10.1097/icu.0000000000001036 article EN Current Opinion in Ophthalmology 2024-02-07

To assess the two-year outcome of intravitreal ziv-aflibercept (IVZ) in eyes with macular diseases.Consecutive subjects various diseases that received six or more 0.05 mL IVZ (1.25 mg) injections at least 1 year follow-up were included. Outcome measures best-corrected visual acuity (BCVA) (logarithm minimum angle resolution) and central thickness (CMT) on spectral domain optical coherence tomography. Paired comparison was done using Wilcoxon signed-rank test calculator.107 91 followed...

10.1136/bjophthalmol-2017-311591 article EN British Journal of Ophthalmology 2018-01-09

To ascertain the anatomic factors that help achieve non-surgical sealing in full thickness macular hole (FTMH).Retrospective collaborative study of FTMH closed without surgical intervention.A total 78 patients (mean age 57.9 years) included 18 with blunt ocular trauma, received topical or intravitreal therapies and 42 idiopathic FTMH. Mean±SD initial corrected visual acuity (VA) logMAR improved from 0.65±0.54 to 0.34±0.45 (p<0.001) at a mean follow-up 33.8±37.1 months. reopened seven eyes...

10.1136/bjophthalmol-2021-319001 article EN British Journal of Ophthalmology 2021-04-29

Abstract The purpose of this study was to examine how demographics, etiology, and clinical examination findings are related visual outcomes in subjects with open globe injury (OGI) across a large generalizable sample. A retrospective cohort analysis performed using data collected from the electronic medical records four tertiary university centers for OGI presenting 2018 2021. Demographic information, mechanisms, exam findings, acuity (VA) at presentation most recent follow-up were recorded....

10.1038/s41598-024-67564-y article EN cc-by Scientific Reports 2024-07-18

Purpose: There is no established therapy for exudative-hemorrhagic complications in primary retinal arteriolar macroaneurysm (RAM). Methods: Retrospective multicenter interventional study of anti-vascular endothelial growth factor symptomatic RAMs. Central macular thickness μ m and best-corrected visual acuity logMar were correlated with the RAM size distance to macula. Statistical analyses performed using paired comparisons Pearson correlation. Results: Thirty-two eyes (32 patients) treated...

10.1097/iae.0000000000002131 article EN Retina 2018-03-04

Ziv-aflibercept (Zaltrap® ), a recombinant fusion protein that binds diffusible vascular endothelial growth factor (VEGF), is approved for the treatment of metastatic colorectal carcinoma. Its molecular structure same as aflibercept (Eylea® thus making it an attractive option off-label chorioretinal conditions. distributed in 4 and 8 ml vials intravenous use, its cost after compounding similar to bevacizumab. Studies with retinal pigment epithelium cytotoxicity, animal histologic sections...

10.1111/aos.14328 article EN Acta Ophthalmologica 2019-12-20

Abstract: This patient presented for surgery at the age of 32 years, 14 months after his initial complaint metamorphopsia and visual loss in right eye. Past tests demonstrated a whitish epiretinal membrane (ERM) with translucent stress lines over thickened macula. Visual acuity was found on last presentation to be normal minimal alteration Amsler grid testing. A torn ERM center left-over temporally rolled-over nasally site epicenter no posterior vitreous detachment. recovery occurred...

10.2147/opth.s74163 article EN cc-by-nc Clinical ophthalmology 2014-11-01

Cancer-associated retinopathy (CAR) is a potentially blinding disease triggered by autoimmunity to cancer antigens at distant sites. It may masquerade as immune-related adverse events from the use of immune checkpoint inhibitors (ICIs). We present patient with an underlying tubby-related protein 1 (TULP1) cancer-associated who lost vision following initiation atezolizumab for small-cell lung cancer. This 75-year-old man presented no light perception, paramacular and peripheral retinal...

10.7759/cureus.21709 article EN Cureus 2022-01-29

To investigate the use of intraocular fibrin glue to lower risk vitreous hemorrhage (VH) after pars plana vitrectomy (PPV) in eyes with diabetic VH or traction retinal detachment.

10.1097/iae.0000000000003597 article EN Retina 2023-02-03

To assess public awareness, interest, and concerns regarding Vuity (1.25% pilocarpine hydrochloride ophthalmic solution), an eye drop for the treatment of presbyopia, based on Google Trends.We used Trends that provides a relative search volume queried terms, to evaluate searches from June 30, 2021, 2022, in United States. The data this study were downloaded 2022. Main outcome measures changes volumes terms "Vuity," "Eye drops reading," near vision," "Presbyopia," "Pilocarpine," related...

10.1371/journal.pone.0293066 article EN cc-by PLoS ONE 2023-10-26

To assess the 30-month outcome of treat and extend (TAE) intravitreal ziv-aflibercept therapy in eyes with macular diseases.In this prospective study, consecutive subjects received 0.05 mL (1.25 mg) injections for various diseases. Outcome measures were best-corrected visual acuity (BCVA) (logarithm minimum angle resolution) central thickness (CMT) on spectral domain optical coherence tomography. Paired comparison was done using Wilcoxon signed-rank test calculator.Fifty-three 48 (33 naïve...

10.1136/bjophthalmol-2018-312593 article EN British Journal of Ophthalmology 2018-08-02

Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disease presenting as sporadic paroxysmal attacks of and abdominal pain. The inflammation serosal spaces, joints, skin caused by the production an abnormal protein called pyrin. Ocular pathology scarce in FMF.Herein we describe case FMF with painful loss vision left eye. Serous macular detachment assessed OCT, leaky pinpoint subretinal foci temporal to fovea examined fluorescein angiography, scleral choroidal thickening seen...

10.1159/000499600 article EN cc-by-nc Case Reports in Ophthalmology 2019-04-18
Coming Soon ...